Nov Ab, Inc. reported raising in an initial SEC Form D filing, from an offering of $600,000
Round Type
Venture
Quick answer
NovAb raised an undisclosed amount in a funding round, dated September 30, 2016. NovAb is based in Tucker, Georgia, United States.
- How much did NovAb raise?
- NovAb raised an undisclosed amount in a funding round on September 30, 2016.
- What does NovAb do?
- NovAb is the developer of monoclonal antibodies (mAbs) designed to utilize variable lymphocyte receptors (VLRs) to develop therapeutic drugs and diagnostic and biomedical research reagents.
- Where is NovAb based and how big is it?
- NovAb is based in Tucker, Georgia, United States. Fundz records about 3 employees.
- Who are the decision-makers at NovAb?
- Fundz holds 1 contact at NovAb. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology around the same time
Companies in the same sectors as NovAb that raised within 45 days of this round, from Fundz verified event records.
- Amyris raised $8.5M on November 14, 2016.
- Aerpio Therapeutics, Inc. raised $3.5M (Seed) on November 14, 2016.
- BNB Plus raised $5M on November 14, 2016.
- Glycomine, Inc. raised $4.9M (Seed) on November 14, 2016.
- Crispr Therapeutics raised $35M on November 4, 2016.
- TuHURA Biosciences raised an undisclosed amount on November 4, 2016.
Who to call at NovAb, and when
A new round usually means NovAb is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day NovAb raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at NovAb, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at NovAb. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment NovAb raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
NovAb raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.